NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands

BACKGROUND: In 2012, around 400.000 patients in the Netherlands were treated with Vitamin K Antagonists (VKA) for thromboembolic diseases. Since 2011, non-VKA oral anticoagulants (NOACs) are available. NOACs do not require frequent INR monitoring which benefits patients, but also imposes a risk of r...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Heuvel, J. M., Hövels, A. M., Büller, H. R., Mantel-Teeuwisse, A. K., de Boer, A., Maitland-van der Zee, A. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905161/
https://www.ncbi.nlm.nih.gov/pubmed/29692686
http://dx.doi.org/10.1186/s12959-017-0156-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905161/
https://www.ncbi.nlm.nih.gov/pubmed/29692686
http://dx.doi.org/10.1186/s12959-017-0156-y

Ejemplares similares